Interference with akt signaling protects against myocardial infarction and death by limiting the consequences of oxidative stress

Science Signaling

Volumn 6, Issue 287, 2013, Pages

  Kerr, Bethany A ^a   Ma, Lining ^a,b   West, Xiaoxia Z ^a   Ding, Liang ^a   Malinin, Nikolay L ^a,g   Weber, Malory E ^a   Tischenko, Mira ^a   Goc, Anna ^c,d   Somanath, Payaningal R ^c,d,e   Penn, Marc S ^f   Podrez, Eugene A ^a   Byzova, Tatiana V ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b HAINAN PROVINCIAL PEOPLE S HOSPITAL   (China)

^c UNIVERSITY OF GEORGIA   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e MEDICAL COLLEGE OF GEORGIA   (United States)

^f Northeastern Ohio Medical University   (United States)

^g UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CD36 ANTIGEN; CHOLESTEROL; PROTEIN AKT1; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; SCAVENGER RECEPTOR BI; UNCLASSIFIED DRUG; AKT1 PROTEIN, MOUSE; SCARB1 PROTEIN, HUMAN; SCAVENGER RECEPTOR B;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR MORTALITY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE COURSE; DYSLIPIDEMIA; ENDOTHELIUM CELL; ENZYME ACTIVATION; EXPERIMENTAL MODEL; FEMALE; FOAM CELL; GENE DELETION; HEART DISEASE; HEART FUNCTION; HEART HYPERTROPHY; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE FIBROSIS; HEART MUSCLE NECROSIS; INFLAMMATION; LIFESPAN; LIPID OXIDATION; LIPID STORAGE; MACROPHAGE; MOUSE; NONHUMAN; OXIDATIVE STRESS; POSITIVE FEEDBACK; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SURVIVAL; ANIMAL; DISEASE MODEL; ENZYMOLOGY; GENETICS; KNOCKOUT MOUSE; METABOLISM; MYOCARDIAL INFARCTION; PATHOLOGY;

MUS;

ANIMALS; ANTIGENS, CD36; APOLIPOPROTEINS E; ATHEROSCLEROSIS; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; MICE; MICE, KNOCKOUT; MYOCARDIAL INFARCTION; OXIDATIVE STRESS; PROTO-ONCOGENE PROTEINS C-AKT; SCAVENGER RECEPTORS, CLASS B; SIGNAL TRANSDUCTION;

EID: 84884149973     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2003948     Document Type: Article

References (65)

1. D. E. Harrison, R. Strong, Z. D. Sharp, J. F. Nelson, C. M. Astle, K. Flurkey, N. L. Nadon, J. E. Wilkinson, K. Frenkel, C. S. Carter, M. Pahor, M. A. Javors, E. Fernandez, R. A. Miller, Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460, 392-395 (2009).
2. D. D. Sarbassov, S. M. Ali, S. Sengupta, J. H. Sheen, P. P. Hsu, A. F. Bagley, A. L. Markhard, D. M. Sabatini, Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol. Cell 22, 159-168 (2006).
3. D. Lloyd-Jones, R. Adams, M. Carnethon, G. De Simone, T. B. Ferguson, K. Flegal, E. Ford, K. Furie, A. Go, K. Greenlund, N. Haase, S. Hailpern, M. Ho, V. Howard, B. Kissela, S. Kittner, D. Lackland, L. Lisabeth, A. Marelli, M. McDermott, J. Meigs, D. Mozaffarian, G. Nichol, C. O?Donnell, V. Roger, W. Rosamond, R. Sacco, P. Sorlie, R. Stafford, J. Steinberger, T. Thom, S. Wasserthiel-Smoller, N. Wong, J. Wylie-Rosett, Y. Hong; American Heart Association Statistics Committee and Stroke Statistics Subcommittee, Heart disease and stroke statistics-2009 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119, 480-486 (2009).
4. R. Ross, Atherosclerosis-An inflammatory disease. N. Engl. J. Med. 340, 115-126 (1999).
5. B. L. Trigatti, M. Krieger, A. Rigotti, Influence of the HDL receptor SR-BI on lipoprotein metabolism and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 23, 1732-1738 (2003).
6. A. Braun, B. L. Trigatti, M. J. Post, K. Sato, M. Simons, J. M. Edelberg, R. D. Rosenberg, M. Schrenzel, M. Krieger, Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-Deficient mice. Circ. Res. 90, 270-276 (2002).
7. B. Trigatti, H. Rayburn, M. Viñals, A. Braun, H. Miettinen, M. Penman, M. Hertz, M. Schrenzel, L. Amigo, A. Rigotti, M. Krieger, Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology. Proc. Natl. Acad. Sci. U.S.A. 96, 9322-9327 (1999).
8. C. Fernández-Hernando, E. Ackah, J. Yu, Y. Suárez, T. Murata, Y. Iwakiri, J. Prendergast, R. Q. Miao, M. J. Birnbaum,W. C. Sessa, Loss of Akt1 leads to severe atherosclerosis and occlusive coronary artery disease. Cell Metab. 6, 446-457 (2007).
9. J. Chen, P. R. Somanath, O. Razorenova,W. S. Chen, N. Hay, P. Bornstein, T. V. Byzova, Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo. Nat. Med. 11, 1188-1196 (2005).
10. B. Chandrasekar, F. M. Marelli-Berg, M. Tone, S. Bysani, S. D. Prabhu, D. R. Murray, b-Adrenergic stimulation induces interleukin-18 expression via b2-AR, PI3K, Akt, IKK, and NF-kB. Biochem. Biophys. Res. Commun. 319, 304-311 (2004).
11. A. Boullier, Y. Li, O. Quehenberger, W. Palinski, I. Tabas, J. L. Witztum, Y. I. Miller, Minimally oxidized LDL offsets the apoptotic effects of extensively oxidized LDL and free cholesterol in macrophages. Arterioscler. Thromb. Vasc. Biol. 26, 1169-1176 (2006).
12. B. DeBosch, I. Treskov, T. S. Lupu, C. Weinheimer, A. Kovacs, M. Courtois, A. J. Muslin, Akt1 is required for physiological cardiac growth. Circulation 113, 2097-2104 (2006).
13. S. Haq, G. Choukroun, H. Lim, K. M. Tymitz, F. Del Monte, J. Gwathmey, L. Grazette, A. Michael, R. Hajjar, T. Force, J. D. Molkentin, Differential activation of signal transduction pathways in human hearts with hypertrophy versus advanced heart failure. Circulation 103, 670-677 (2001).
14. N. Sopko, Y. Qin, A. Finan, A. Dadabayev, S. Chigurupati, J. Qin, M. S. Penn, S. Gupta, Significance of thymosin b4 and implication of PINCH-1-ILK-A-Parvin (PIP) complex in human dilated cardiomyopathy. PLoS One 6, e20184 (2011).
15. I. Bjedov, J. M. Toivonen, F. Kerr, C. Slack, J. Jacobson, A. Foley, L. Partridge, Mechanisms of life span extension by rapamycin in the fruit fly Drosophila melanogaster. Cell Metab. 11, 35-46 (2010).
16. M. A. Lawlor, D. R. Alessi, PKB/Akt: A key mediator of cell proliferation, survival and insulin responses? J. Cell Sci. 114, 2903-2910 (2001).
17. P. R. Somanath, O. V. Razorenova, J. Chen, T. V. Byzova, Akt1 in endothelial cell and angiogenesis. Cell Cycle 5, 512-518 (2006).
18. S. Araki, Y. Izumiya, S. Hanatani, T. Rokutanda, H. Usuku, Y. Akasaki, T. Takeo, N. Nakagata, K. Walsh, H. Ogawa, Akt1-Mediated skeletal muscle growth attenuates cardiac dysfunction and remodeling after experimental myocardial infarction. Circ. Heart Fail. 5, 116-125 (2012).
19. I. Shiojima, K. Sato, Y. Izumiya, S. Schiekofer, M. Ito, R. Liao, W. S. Colucci, K. Walsh, Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J. Clin. Invest. 115, 2108-2118 (2005).
20. I. Shimizu, T. Minamino, H. Toko, S. Okada, H. Ikeda, N. Yasuda, K. Tateno, J. Moriya, M. Yokoyama, A. Nojima, G. Y. Koh, H. Akazawa, I. Shiojima, C. R. Kahn, E. D. Abel, I. Komuro, Excessive cardiac insulin signaling exacerbates systolic dysfunction induced by pressure overload in rodents. J. Clin. Invest. 120, 1506-1514 (2010).
21. M. Los, S. Maddika, B. Erb, K. Schulze-Osthoff, Switching Akt: From survival signaling to deadly response. Bioessays 31, 492-495 (2009).
22. I. Dolado, A. R. Nebreda, AKT and oxidative stress team up to kill cancer cells. Cancer Cell 14, 427-429 (2008).
23. K. Tsuchiya, J. Tanaka, Y. Shuiqing, C. L. Welch, R. A. DePinho, I. Tabas, A. R. Tall, I. J. Goldberg, D. Accili, FoxOs integrate pleiotropic actions of insulin in vascular endothelium to protect mice from atherosclerosis. Cell Metab. 15, 372-381 (2012).
24. R. A. Miller, D. E. Harrison, C. M. Astle, J. A. Baur, A. R. Boyd, R. De Cabo, E. Fernandez, K. Flurkey, M. A. Javors, J. F. Nelson, C. J. Orihuela, S. Pletcher, Z. D. Sharp, D. Sinclair, J. W. Starnes, J. E. Wilkinson, N. L. Nadon, R. Strong, Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. J. Gerontol. A Biol. Sci. Med. Sci. 66, 191-201 (2011).
25. V. Nogueira, Y. Park, C. C. Chen, P. Z. Xu, M. L. Chen, I. Tonic, T. Unterman, N. Hay, Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. Cancer Cell 14, 458-470 (2008).
26. B. T. O?Neill, E. D. Abel, Akt1 in the cardiovascular system: Friend or foe? J. Clin. Invest. 115, 2059-2064 (2005).
27. V. Ulici, K. D. Hoenselaar, H. Agoston, D. D. McErlain, J. Umoh, S. Chakrabarti, D. W. Holdsworth, F. Beier, The role of Akt1 in terminal stages of endochondral bone formation: Angiogenesis and ossification. Bone 45, 1133-1145 (2009).
28. P. R. Somanath, J. Chen, T. V. Byzova, Akt1 is necessary for the vascular maturation and angiogenesis during cutaneous wound healing. Angiogenesis 11, 277-288 (2008).
29. P. R. Somanath, E. S. Kandel, N. Hay, T. V. Byzova, Akt1 signaling regulates integrin activation, matrix recognition, and fibronectin assembly. J. Biol. Chem. 282, 22964-22976 (2007).
30. P. Libby, Inflammation in atherosclerosis. Nature 420, 868-874 (2002).
31. M. I. Cybulsky, M. A. Gimbrone Jr., Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 251, 788-791 (1991).
32. T. Minami, M. R. Abid, J. Zhang, G. King, T. Kodama, W. C. Aird, Thrombin stimulation of vascular adhesion molecule-1 in endothelial cells is mediated by protein kinase C (PKC)-D-NF-kB and PKC-z-GATA signaling pathways. J. Biol. Chem. 278, 6976-6984 (2003).
33. R. A. Dweik, Nitric oxide, hypoxia, and superoxide: The good, the bad, and the ugly! Thorax 60, 265-267 (2005).
34. X. Z. West, N. L. Malinin, A. A. Merkulova, M. Tischenko, B. A. Kerr, E. C. Borden, E. A. Podrez, R. G. Salomon, T. V. Byzova, Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands. Nature 467, 972-976 (2010).
35. M. Karin, The NF-kB activation pathway: Its regulation and role in inflammation and cell survival. Cancer J. Sci. Am. 4 (Suppl. 1), S92-S99 (1998).
36. J. A. Romashkova, S. S. Makarov, NF-kB is a target of AKT in anti-Apoptotic PDGF signalling. Nature 401, 86-90 (1999).
37. E. A. Podrez, E. Poliakov, Z. Shen, R. Zhang, Y. Deng, M. Sun, P. J. Finton, L. Shan, M. Febbraio, D. P. Hajjar, R. L. Silverstein, H. F. Hoff, R. G. Salomon, S. L. Hazen, A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions. J. Biol. Chem. 277, 38517-38523 (2002).
38. N. S. Kar, M. Z. Ashraf, M. Valiyaveettil, E. A. Podrez, Mapping and characterization of the binding site for specific oxidized phospholipids and oxidized low density lipoprotein of scavenger receptor CD36. J. Biol. Chem. 283, 8765-8771 (2008).
39. E. D. Abel, T. Doenst, Mitochondrial adaptations to physiological vs. pathological cardiac hypertrophy. Cardiovasc. Res. 90, 234-242 (2011).
40. X. A. Li,W. B. Titlow, B. A. Jackson, N. Giltiay, M. Nikolova- Karakashian, A. Uittenbogaard, E. J. Smart, High density lipoprotein binding to scavenger receptor, class B, type I activates endothelial nitric-Oxide synthase in a ceramide-Dependent manner. J. Biol. Chem. 277, 11058-11063 (2002).
41. M. Spiecker, H. B. Peng, J. K. Liao, Inhibition of endothelial vascular cell adhesion molecule-1 expression by nitric oxide involves the induction and nuclear translocation of IkBa. J. Biol. Chem. 272, 30969-30974 (1997).
42. M. Minhajuddin, K. M. Bijli, F. Fazal, A. Sassano, K. I. Nakayama, N. Hay, L. C. Platanias, A. Rahman, Protein kinase C-D and phosphatidylinositol 3-kinase/Akt activatemammalian target of rapamycin to modulate NF-kB activation and intercellular adhesion molecule-1 (ICAM-1) expression in endothelial cells. J. Biol. Chem. 284, 4052-4061 (2009).
43. J. Chen, S. De, D. S. Damron, W. S. Chen, N. Hay, T. V. Byzova, Impaired platelet responses to thrombin and collagen in AKT-1-Deficient mice. Blood 104, 1703-1710 (2004).
44. H. Yin, A. Stojanovic, N. Hay, X. Du, The role of Akt in the signaling pathway of the glycoprotein Ib-IX-Induced platelet activation. Blood 111, 658-665 (2008).
45. G. Condorelli, A. Drusco, G. Stassi, A. Bellacosa, R. Roncarati, G. Iaccarino, M. A. Russo, Y. Gu, N. Dalton, C. Chung, M. V. Latronico, C. Napoli, J. Sadoshima, C. M. Croce, J. Ross Jr., Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 99, 12333-12338 (2002).
46. T. Shioi, J. R. McMullen, P. M. Kang, P. S. Douglas, T. Obata, T. F. Franke, L. C. Cantley, S. Izumo, Akt/protein kinase B promotes organ growth in transgenic mice. Mol. Cell. Biol. 22, 2799-2809 (2002).
47. G. J. Kops, T. B. Dansen, P. E. Polderman, I. Saarloos, K. W. Wirtz, P. J. Coffer, T. T. Huang, J. L. Bos, R. H. Medema, B. M. Burgering, Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 419, 316-321 (2002).
48. S. Nemoto, T. Finkel, Redox regulation of forkhead proteins through a p66shcdependent signaling pathway. Science 295, 2450-2452 (2002).
49. X. N. Li, J. Song, L. Zhang, S. A. LeMaire, X. Hou, C. Zhang, J. S. Coselli, L. Chen, X. L. Wang, Y. Zhang, Y. H. Shen, Activation of the AMPK-FOXO3 pathway reduces fatty acid-Induced increase in intracellular reactive oxygen species by upregulating thioredoxin. Diabetes 58, 2246-2257 (2009).
50. D. Marinkovic, X. Zhang, S. Yalcin, J. P. Luciano, C. Brugnara, T. Huber, S. Ghaffari, Foxo3 is required for the regulation of oxidative stress in erythropoiesis. J. Clin. Invest. 117, 2133-2144 (2007).
51. Z. Tothova, R. Kollipara, B. J. Huntly, B. H. Lee, D. H. Castrillon, D. E. Cullen, E. P. McDowell, S. Lazo-Kallanian, I. R. Williams, C. Sears, S. A. Armstrong, E. Passegué, R. A. DePinho, D. G. Gilliland, FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 128, 325-339 (2007).
52. M. Febbraio, E. A. Podrez, J. D. Smith, D. P. Hajjar, S. L. Hazen, H. F. Hoff, K. Sharma, R. L. Silverstein, Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J. Clin. Invest. 105, 1049-1056 (2000).
53. M. Janabi, S. Yamashita, K. Hirano, N. Sakai, H. Hiraoka, K. Matsumoto, Z. Zhang, S. Nozaki, Y. Matsuzawa, Oxidized LDL-Induced NF-kB activation and subsequent expression of proinflammatory genes are defective in monocyte-Derived macrophages from CD36-Deficient patients. Arterioscler. Thromb. Vasc. Biol. 20, 1953-1960 (2000).
54. A. S. Antonov, F. D. Kolodgie, D. H. Munn, R. G. Gerrity, Regulation of macrophage foam cell formation by aVb3 integrin: Potential role in human atherosclerosis. Am. J. Pathol. 165, 247-258 (2004).
55. W. Ming Cao, K. Murao, H. Imachi, M. Sato, T. Nakano, T. Kodama, Y. Sasaguri, N. C. Wong, J. Takahara, T. Ishida, Phosphatidylinositol 3-OH kinase-Akt/protein kinase B pathway mediates Gas6 induction of scavenger receptor a in immortalized human vascular smooth muscle cell line. Arterioscler. Thromb. Vasc. Biol. 21, 1592-1597 (2001).
56. S. H. Lee, D. W. Park, S. C. Park, Y. K. Park, S. Y. Hong, J. R. Kim, C. H. Lee, S. H. Baek, Calcium-Independent phospholipase A2b-Akt signaling is involved in lipopolysaccharide-Induced NADPH oxidase 1 expression and foam cell formation. J. Immunol. 183, 7497-7504 (2009).
57. H. Y. Chung, M. Cesari, S. Anton, E. Marzetti, S. Giovannini, A. Y. Seo, C. Carter, B. P. Yu, C. Leeuwenburgh, Molecular inflammation: Underpinnings of aging and age-Related diseases. Ageing Res. Rev. 8, 18-30 (2009).
58. M. Lu, M.Wan, K. F. Leavens, Q. Chu, B. R. Monks, S. Fernandez, R. S. Ahima, K. Ueki, C. R. Kahn, M. J. Birnbaum, Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1. Nat. Med. 18, 388-395 (2012).
59. D. K. Singla, G. E. Lyons, T. J. Kamp, Transplanted embryonic stem cells following mouse myocardial infarction inhibit apoptosis and cardiac remodeling. Am. J. Physiol. Heart Circ. Physiol. 293, H1308-H1314 (2007).
60. S. Agrawal, M. Febbraio, E. Podrez, M. K. Cathcart, G. R. Stark, G. M. Chisolm, Signal transducer and activator of transcription 1 is required for optimal foam cell formation and atherosclerotic lesion development. Circulation 115, 2939-2947 (2007).
61. E. A. Podrez, E. Poliakov, Z. Shen, R. Zhang, Y. Deng, M. Sun, P. J. Finton, L. Shan, B. Gugiu, P. L. Fox, H. F. Hoff, R. G. Salomon, S. L. Hazen, Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36. J. Biol. Chem. 277, 38503-38516 (2002).
62. K. Iiyama, L. Hajra, M. Iiyama, H. Li, M. DiChiara, B. D. Medoff, M. I. Cybulsky, Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation. Circ. Res. 85, 199-207 (1999).
63. F. J. Miller Jr., D. D. Gutterman, C. D. Rios, D. D. Heistad, B. L. Davidson, Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ. Res. 82, 1298-1305 (1998).
64. J. W. Crabb, M. Miyagi, X. Gu, K. Shadrach, K. A. West, H. Sakaguchi, M. Kamei, A. Hasan, L. Yan, M. E. Rayborn, R. G. Salomon, J. G. Hollyfield, Drusen proteome analysis: An approach to the etiology of age-Related macular degeneration. Proc. Natl. Acad. Sci. U.S.A. 99, 14682-14687 (2002).
65. Z. P. Cai, Z. Shen, L. Van Kaer, L. C. Becker, Ischemic preconditioning-Induced cardioprotection is lost in mice with immunoproteasome subunit low molecular mass polypeptide-2 deficiency. FASEB J. 22, 4248-4257 (2008).